Sandy Wong, MD

Hematologist

Dr. Sandy Wong sees patients in the Hematology and Blood and Marrow Transplant Clinic, where she cares for people with MGUS, smoldering myeloma, multiple myeloma and amyloidosis.

Wong has a special interest in amyloidosis patients and her research focuses on that disease. She studies AL amyloidosis patients with renal involvement, as well as those with cytogenetic abnormalities, such as deletion 17p. Wong also is designing a clinical trial for a promising new drug to treat multiple myeloma.

Wong graduated from Brown University with a degree in human biology, earning her medical degree at the University of Massachusetts. She then completed an internal medicine residency followed by a hematology/oncology fellowship at Tufts Medical Center in Boston.

An assistant clinical professor at UCSF, Wong is a member of the American Society of Hematology and the American Society of Clinical Oncology.

Clinics

Hematology and Blood and Marrow Transplant
400 Parnassus Ave., 4th Floor
San Francisco, CA 94143
Existing Patients: (415) 353-2421
Fax: (415) 353-2467

Hours: Monday to Friday
8 a.m. – 5 p.m

Board Certification

Internal Medicine, American Board of Internal Medicine

Academic Title

Assistant Professor

More about Sandy Wong

Additional Languages

Cantonese
English

Education

University of Massachusetts School of Medicine 2009

Residencies

Tufts Medical Center 2012

Fellowships

Tufts Medical Center 2016

Selected Research and Publications

  1. Lam C, Ferguson ID, Mariano MC, Lin YT, Murnane M, Liu H, Smith GA, Wong SW, Taunton J, Liu JO, Mitsiades CS, Hann BC, Aftab BT, Wiita AP. Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica. 2018 Apr 05.
  2. Wong SW, Toskic D, Warner M, Varga C, Moreno-Koehler A, Fein D, Fogaren T, Lee L, Oliver CM, Guthrie SD, Comenzo RL. Primary Amyloidosis With Renal Involvement: Outcomes in 77 Consecutive Patients at a Single Center. Clin Lymphoma Myeloma Leuk. 2017 Nov; 17(11):759-766.
  3. Wong SW, Larivee D, Warner M, Sprague KA, Fogaren T, Comenzo RL. Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy. Bone Marrow Transplant. 2017 06; 52(6):936-937.
  4. Sandy W. Wong, Melissa Warner, Alejandro Moreno-Koehler, Athena Kritharis, Michael E. Coyle, Deborah Black, Valerie Relias, Terry Fogaren, Nancy Cody Lyons, Francois Toka, Denise Larivee, Andrew M. Evens, Grace Kao, Kellie Sprague, Andreas K. Klein, Kenneth B. Miller, Raymond L. Comenzo. Toxicities, response and survival: Autologous stem cell transplantation for multiple myeloma over 25 years at a single center. Cancer Treatment and Research Communications. 2017; 11:1-5.
  5. Ma X, Zhou P, Wong SW, Warner M, Chaulagain C, Comenzo RL. siRNA targeting the ? light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases. Gene Ther. 2016 Oct; 23(10):727-733.
  6. Weiss BM, Wong SW, Comenzo RL. Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosis. Blood. 2016 05 12; 127(19):2275-80.
  7. Wong SW, Comenzo RL. CD38 Monoclonal Antibody Therapies for Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2015 Nov; 15(11):635-45.
  8. Yuan Z, Liu X, Wong S, Machan JT, Chung MA. MUC1 Knockdown With RNA Interference Inhibits Pancreatic Cancer Growth. J Surg Res. 2009 Nov; 157(1):e39-46.
  9. Yuan Z, Wong S, Borrelli A, Chung MA. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. Biochem Biophys Res Commun. 2007 Oct 26; 362(3):740-6.
  10. Shaw MH, Boyartchuk V, Wong S, Karaghiosoff M, Ragimbeau J, Pellegrini S, Muller M, Dietrich WF, Yap GS. A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. Proc Natl Acad Sci U S A. 2003 Sep 30; 100(20):11594-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.